APR 29·Stock Titan→
Director at Nuwellis (NUWE) granted 6,744 stock options at $1.16
Nuwellis, Inc. director Archelle Georgiou Feldshon was granted 6,744 nonstatutory stock options with an exercise price of $1.16 per share, expiring on April 27, 2036. These options will vest in 12 equal monthly installments over one year, representing a compensation-related equity grant rather than a market purchase. The transaction details were disclosed in an SEC Form 4 filing on April 29, 2026.
APR 28·Stock Titan▲
Catheter cut to fit at bedside gets USPTO allowance for Nuwellis
Nuwellis (Nasdaq: NUWE) announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a patent covering its dual lumen midline catheter technology, designed for ultrafiltration therapies. This innovative catheter allows for bedside length customization while maintaining kink resistance and stable flow, aiming to improve patient outcomes and clinician experience. The technology is intended to complement Nuwellis' Aquadex SmartFlow® system and expand access to ultrafiltration in both hospital and outpatient settings.
